Advertisement

Related Videos

Varsha Gandhi, PhD, on Ibrutinib

Opportunities to Optimize Cancer Policies Panel Discussion

Deborah Collyar: What's In It for Patients?

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Advertisement

Advertisement




Mar
19
Today In Oncology
Timely Scans May Reduce Mortality in Patients Who Present to the ER With Hematuria
PSMA PET-CT Scan Reduces Need for Prostate Cancer Biopsies
New AACR President-Elect and Board Members Announced
Activity Observed With Novel KRAS Inhibitor in Pancreatic Cancer (1)
Neoadjuvant/Adjuvant Doublet Significantly Improved Survival in Patients With Muscle-Invasive Bladder Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo